findmyKOL
Clinical trialNCT00103376TerminatedPhase 2Interventional

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

SponsorMedical University of South CarolinaEnrollment23Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Loma Linda University Cancer Institute at Loma Linda University Medical Center

    Loma Linda, California, United States

  • Hollings Cancer Center at Medical University of South Carolina

    Charleston, South Carolina, United States

  • South Carolina Oncology Associates, Pa

    Columbia, South Carolina, United States

  • Gibbs Regional Cancer Center at Spartanburg Regional Medical Center

    Spartanburg, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2004
Primary completion
31 Oct 2009
Completion
30 Jun 2011
Last update posted
5 Nov 2018
Registered enrollment
23
Registry id
NCT00103376
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.